Erika L. Hellenbart
Clinical Assistant Professor, College of Pharmacy - Pharmacy Practice
Contact
Office Phone:
Email:
Related Sites:
About Heading link
Teaching and Supervision Heading link
MDC 604 Block 4: Circulation & Respiration (MDC 604 Block 4: Circulation & Respiration), 3/15/2023 – 3/15/2023
PDAT 5: Cardiovascular (PHAR 505), 1/9/2023 – 4/28/2023
PDAT 5: Cardiovascular (PHAR 505), 1/9/2023 – 4/28/2023
Adv Topics in Ambulatory Care (PMPR 348), 1/9/2023 – 4/28/2023
Adv Topics in Ambulatory Care (PMPR 348), 1/9/2023 – 4/28/2023
NURS 533 Applied Pharmacology (NURS 533), 11/3/2022 – 11/3/2022
NURS 534: Management of Health and Illness 1 (NURS 534), 9/22/2022 – 9/22/2022
Adv Topics in Ambulatory Care (PMPR 348), 1/10/2022 – 4/29/2022
PDAT 5: Cardiovascular (PHAR 505), 1/10/2022 – 4/29/2022
Selected Grants
PRogram to Educate & VaccinatE uNderserved members of The public (PREVENT) Pilot, Mobile Care Fdn., 11/1/2022 - 5/31/2024, Obligated Amount: $17325; Anticipated Amount: $17325
COVID-19 Outpatient thrombosis prevention trial (ACTIV 4B), National Institutes of Health and National Heart, Lung, and Blood Institute., 12/1/2020 - 8/12/2021, No Obligated Amount Set; No Anticipated Amount Set
COVID-19 Outpatient thrombosis prevention trial (ACTIV 4B), National Institutes of Health and National Heart, Lung, and Blood Institute., 12/1/2020 - 8/12/2021, No Obligated Amount Set; No Anticipated Amount Set
Impact of socio-environmental factors on optimal anticoagulation outcomes in underserved patients, University of Illinois at Chicago, College of Pharmacy: Riback Grant., 2018 - 2019, No Obligated Amount Set; No Anticipated Amount Set
Global registry on long-term oral anti-thrombotic treatment in patients with atrial fibrillation, Boehringer Ingelheim., 2016 - 2019, No Obligated Amount Set; No Anticipated Amount Set
Patient-centered anticoagulation self-monitoring in minority patients, National Institutes of Health., 2016 - 2017, No Obligated Amount Set; No Anticipated Amount Set
Impact of novel oral anticoagulants on quality of life in an inner-city underserved population, American Pharmacists Association: APhA Incentive Grants for Practitioner Innovation in Pharmaceutical Care 2012., 2012 - 2013, Obligated Amount: $1000; Anticipated Amount: $1000
Selected Publications
Hellenbart, Erika, Cuellar, sandra. (2023). Updates in cardio-oncology. American College of Clinical Pharmacy Ambulatory Care Self-Assessment Program.
Shapiro, Nancy, Hellenbart, Erika. (2023). Koda-Kimble and Young’s Applied Therapeutics: The Clinical Use of Drugs, Twelfth edition textbook. Wolters Kluwer Health, Inc.. Applied Therapeutics: The Clinical Use of Drugs, Twelfth edition. Wolters Kluwer Health, Inc.
Elmes, Abigail T, Hellenbart, Erika L. (2022). Vericiguat (Verquvo) for the Treatment of Heart Failure.. American Family Physician, 106, (5), 582-583.
★ Whittemore, Hannah, Posen, Andrew K, Hellenbart, Erika L, Groo, Vicki, Wenzler, Eric, Tilton, Jessica J. (2021). The Impact of Body Weight and Renal Function on the Risk of Bleeding With Direct Oral Anticoagulants in Atrial Fibrillation. Annals of Pharmacotherapy, 55, (11), 1309-1317. doi:10.1177/1060028021995201.
Shapiro, Nancy, Hellenbart, Erika. (2021). Applied Therapeutics: The Clinical Use of Drugs. Applied Therapeutics: The Clinical Use of Drugs. Wolters Kluwer Health, Inc.
Hellenbart, Erika L, Griffin, Tina, DiDomenico, Robert J. (2020). Beyond Heart Failure and Ischemic Heart Disease: A Scoping Review of Novel Uses of Ivabradine in Adults. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, 40, (6), 544-564. doi:10.1002/phar.2391.
Hellenbart, Erika L. (2017). Venous Thromboembolism and Pregnancy. Oral Anticoagulation Therapy. (pp. 259-267). Springer Nature. doi:10.1007/978-3-319-54643-8_37.
Hellenbart, Erika, Drambarean, Beatrice, Lee, James, Nutescu, Edith A. (2015). The evolving role of dabigatran etexilate in clinical practice. Expert Opinion on Pharmacotherapy, 16, (13), 2053-2072. doi:10.1517/14656566.2015.1074179.
Nutescu, Edith, Chuatrisorn, Ittiporn, Hellenbart, Erika. (2011). Drug and dietary interactions of warfarin and novel oral anticoagulants: an update. Journal of Thrombosis and Thrombolysis, 31, (3), 326-343. doi:10.1007/s11239-011-0561-1.
Hellenbart, Erika L, Faulkenberg, Kathleen D, Finks, Shannon W. Evaluation of bleeding in patients receiving direct oral anticoagulants. Vascular Health and Risk Management, 13, 325-342. doi:10.2147/vhrm.s121661.
Professional Leadership
Cardiology PRN Nominations Committee, 12/1/2022 - 12/1/2023
Cardiology PRN Nominations Committee, 12/1/2021 - 12/1/2022
Planning Committee, American College of Clinical Pharmacy, 11/5/2020 - 10/21/2022
Education
Degrees:
Doctor of Pharmacy (Cum Laude), Ohio State University, United States, 2009
Bachelor of Science, University of Windsor, Canada, 2005
Postgraduate Training:
ASHP-Accredited PGY-1 Pharmacy Residency, Midwestern University Chicago College of Pharmacy, United States, 2010
Licensures and Certifications
Board Certified Pharmacotherapy Specialist, Board of Pharmacy Specialties, 1/1/2010 - Present
Registered Pharmacist, State of Illinois, 1/1/2009 - Present
APhA Pharmacy-Based Immunization Delivery, American Pharmacists Association, 1/1/2007 - Present
Heartsaver® AED Program, American Heart Association, 1/1/2007 - Present
Residents Teaching and Learning Curriculum, Midwestern University, 2009 - 2010
Illinois Poison Prevention Education Training, State of Illinois, 2009 - 2010
Selected Presentations
Hellenbart, Erika. (2023 November 13). Late Breaking Clinical Trials: Ambulatory Care. 2023 American College of Clinical Pharmacy Annual Meeting. Dallas, TX.
Hellenbart, Erika. (2023 October 06). Already on a maximally tolerated statin: now what?. 2023 Cardiovascular Symposium for Primary Care & Hospital Medicine Providers. Chicago, IL.
Hellenbart, Erika. (2023 September 23). Already on a maximally tolerated statin? What next?. Illinois Chapter American College of Cardiology Annual Symposium. Chicago, IL.